Cooley M&A

JANUARY 23, 2024

Why did life sciences outperform the market? Of course, while blockbuster acquisitions always get the headlines, smaller deals actually commanded the market , pacing at 160% of their 2022 levels. More than half of all life sciences M&A activity in 2023 was for private and small-cap biopharma sellers. billion, Mirati for $5.8

Marketability 52

Marketability Equity Private Equity Firm Finance 52

Brian DeChesare

APRIL 19, 2023

The sources of growth also matter; emerging markets’ infrastructure spending drove up metal consumption for a long time, but now there’s a rising demand in developed markets due to EVs and renewable energy. As a result, they operate in more of a global market, with fewer regional disparities. and Industrias Peñoles (Mexico).

Banking 52

Banking Start-ups Private Equity Firm Equity 52

Global Finance

APRIL 3, 2025

In the final stretch of its Vision 2030 development blueprint, Saudi Arabia is counting on FDI to play a bigger role. Initially expected to be taken up by 540 companies by 2030, the kingdom surpassed this goal within the first year. The clock is ticking for Saudi Arabia. Not everyone is rushing through the door, however.

Start-ups 64

Start-ups Private Equity Firm Finance Equity 64